GTM strategy · Humanlinker
Why is Humanlinker growing?
Working document ·
Analysis published: verdict, drivers and playbook with dated sources. I update it when new evidence comes in.
gtm-rx-v1 · Website ↗
Humanlinker grew on the LinkedIn series from 21 to 28 employees (+33%, 2025-01-01 to 2026-01-01). Documented are a 14-day trial without credit card, a partner program paying 20 percent per active subscription with 18 listed integrators, and 54 G2 reviews. Whether these levers drove headcount is open. The series has sat at 28 since October 2025 and Positive acquired the company on 2026-10-27. Revenue, current team size and the LinkedIn match are open.
Headcount: 21 → 28 (+33% / 12M, 2026-01-01)
My verdict
- What works
- A build-out is documented: no-card trial, a partner program with 18 integrators and a deliberate review push. The team grew 33 percent in 2025.
- What does not work or is unproven
- The effect of these levers is not documented. The target of 50 employees and the 15 million euro Series A are not shown as reached, the series has been at 28 since October 2025.
- Transferable to
- Transferable to small B2B vendors with an entry price under 100 euros per user and an environment of agencies that advise customers.
The growth drivers
Trial without card, entry from 69 euros
ObservationProduct-led salesThe pricing page offers a 14-day trial without a credit card and a Pro plan at 69 euros per user per month. Business and Enterprise run only through a demo on request. How many trials convert is not public.
Partner network with 18 integrators and 20 percent
ObservationPartner ecosystemThe partner page lists 18 integrators, including agencies and consultants, and pays affiliates 20 percent per active subscription. Programs for schools and VC accelerators sit alongside. The revenue share of this channel is not documented.
Review build-up per tool vendor Jimo
Company statementContent-ledG2 shows 4.5 out of 5 across 54 reviews. The tool vendor Jimo, which has its own interest, describes an in-app campaign that produced 40 new G2 reviews from 486 views, and its title says 70 instead of 54. That it produced new customers is not documented.
Personal outreach instead of mass sending
Company statementFounder-ledThe CEO told Maddyness in 2024 that mass prospecting would run out of steam and that Humanlinker bets on deep personalization. DISC analysis, the acquired MyProfilia and the new meeting-prep feature fit that. The effect remains a company statement.
GTM fingerprint
Twelve reviewed ratings from the analysis (0–5), projected language-independently — the same shape in every language, comparable across tools.
- Product-led salesPrimary · Acquisition
14-Tage-Test und Pro-Plan als Einstieg, Business und Enterprise über Demo.
- Partner ecosystemSecondary · Acquisition
18 Integratoren und 20 Prozent Affiliate-Provision.
- Founder-ledSecondary · Awareness
CEO in Presse (Maddyness 2024), Podcast und Konferenzen laut Pressseite.
- Content-ledEmerging · Conversion
Rezensionsaufbau auf G2 (laut Jimo auch Capterra), Akademie und Presse laut Pressseite.
Evidence table: maturity and strength of evidence per axis
| Axis | Maturity | Evidence | Note |
|---|---|---|---|
| Growth outcomes | 3/5 | 55 % | |
| Inflection timeline | 2/5 | 50 % | |
| Market & ICP | 3/5 | 45 % | |
| Positioning & messaging | 3/5 | 40 % | |
| Product wedge | 3/5 | 40 % | |
| Acquisition & distribution | 3/5 | 50 % | |
| Activation & conversion | 2/5 | 30 % | weak evidence |
| Monetisation & sales | 2/5 | 55 % | |
| Retention & expansion | 0/5 | 10 % | weak evidence |
| Org & execution | 2/5 | 35 % | weak evidence |
| Growth loops | 1/5 | 25 % | weak evidence |
| Causal synthesis | 2/5 | 30 % | weak evidence |
Maturity from 0 to 5 describes how pronounced and repeatable the observed mechanism is. Evidence from 0 to 100 describes how strong and independent the sources are. Both describe only this measure, not the quality of the company.
How to copy this
The actionable steps behind this growth — each mapped to the open 12-lever framework.
- 1
On Monday, build a no-card trial and a clearly priced entry plan into your product and measure how many trials pay.
SHAPE · Lever 6Effort: low - 2
Draw up a list of 10 agencies and consultants who already use your product and offer them 20 percent per active subscription.
AMPLIFY · Lever 9Effort: medium - 3
Add a review request after the first success moment in the product and count the G2 reviews.
SHAPE · Lever 5Effort: low
Sources
- Humanlinker vise une série A · Maddyness · 2024-05-28
- Positive übernimmt Humanlinker (Käufer) · Positive · 2026-10-27
- Humanlinker Review 2026 (Agentur-Eigeninteresse) · Hack'celeration · 2026-11-16
- Humanlinker Bewertungen · G2 · 2026-11-16
- Jimo-Fallstudie (Anbieter, Eigeninteresse) · Jimo · 2026-11-16
- Preisseite · Humanlinker · 2026-11-16
- Partner und Affiliate · Humanlinker · 2026-11-16
- Pressseite · Humanlinker · 2026-11-16
Method: evidence-based GTM analysis (GTM-RX)
We reconstruct the go-to-market strategy from dated, publicly available sources. Observable facts, statements by the company and our assessments are labelled separately. Every key statement points to its source and the period it covers. Contradictions and missing data stay visible.
Team growth, job postings, pricing and product changes are signals. They prove neither revenue growth nor that a particular GTM measure succeeded. We judge transferability to other companies by target customers, business model, sales motion and available resources.
In addition, we look at the organisational prerequisites for AI through a TOE / dynamic capabilities lens from the AI Monitor research. This lens does not replace a company survey. Capabilities that cannot be evidenced publicly are rated as unknown. GTM-RX is not a scientific impact study and not a recommendation for a particular tool.
How statements are labelled
- Observation
- Directly measured or documented, with source and date.
- Company statement
- Statement by the company, not independently verified.
- Assessment
- Our assessment: timing, mechanism and evidence support the conclusion.
- Hypothesis
- Open explanation: coincided in time, cause not evidenced.
Analysis of 16 November 2026 · Sources as of 16 November 2026 · Version gtm-rx-v1 · 8 sources checked
Team trend and turning points
Headcount growth
Based on LinkedIn data.
- 2021-01-01
Gründung von Humanlinker
Maddyness nennt 2021, Positive Ende 2020, nur Jahresangabe, Tag 01 ersetzt.
- 2022-04-11
Seed über 2.5 Mio. EUR
Erste Einstellungen nach der Runde, vorher zu zweit, beides laut Maddyness. Seed-Datum laut thesaasnews.
- 2023-05-04
Rund zehn Mitarbeitende
Die Reihe hat 10 (2023-01-01) und 13 (2024-01-01), passt als Grössenordnung.
- 2024-05-28
Serie A über 15 Mio. EUR angekündigt
Ziel rund 50 Mitarbeitende, erreicht sind 28. Abschluss der Runde nicht belegt.
- 2025-10-01
Reihe erreicht 28 und bleibt flach
Seit diesem Punkt keine Veränderung bis 2026-01-01.
- 2026-10-27
Positive übernimmt Humanlinker
Eingliederung in die Sales-Sparte mit noCRM. Positive nennt rund 8000 noCRM-Nutzer, eine Wertung als Vertriebsweg ist nicht belegt.
Observed GTM signals
Observations from stored data, not an analysis. They show where the GTM strategy starts; the full analysis explains why.
- Team trend
- Growing: +33% in 12 months, +115% in 24 months.
- Team today: 28 (2026-01-01)
- Competitive set
- Outreach, Salesloft, Apollo.io
Similar companies
Similar means: same category, then the same pricing model, similar team size and region (rule similar/1). Empty groups are not shown.
Similar companies with observed team growth
More similar companies: team size flat or shrinking
Similar companies with unclear data
FAQ
- Why is Humanlinker growing?
- Humanlinker grew on the LinkedIn series from 21 to 28 employees (+33%, 2025-01-01 to 2026-01-01). Documented are a 14-day trial without credit card, a partner program paying 20 percent per active subscription with 18 listed integrators, and 54 G2 reviews. Whether these levers drove headcount is open. The series has sat at 28 since October 2025 and Positive acquired the company on 2026-10-27. Revenue, current team size and the LinkedIn match are open.
- Which GTM motion does Humanlinker use?
- The strongest observed GTM motions at Humanlinker are: Product-led sales.
- How fast is Humanlinker growing?
- Humanlinker's headcount grew from 21 to 28 employees (+33% over 12 months, based on LinkedIn data).
Put it to work
The method behind these patterns is in the playbook of The Science of GTM. If you want to build a GTM engine on this model, Pedalix implements it with you.